Resveratrol is cidal to both classes of Haemophilus ducreyi.
暂无分享,去创建一个
[1] Jacques Ravel,et al. Vaginal microbiome: rethinking health and disease. , 2012, Annual review of microbiology.
[2] K. Workowski,et al. Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] C. Bonechi,et al. Increased susceptibility to resveratrol of Helicobacter pylori strains isolated from patients with gastric carcinoma. , 2011, Journal of natural products.
[4] Stuart Berman,et al. Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[5] Susana Ferreira,et al. Antimicrobial activity and effects of resveratrol on human pathogenic bacteria , 2010 .
[6] B. Katz,et al. Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience. , 2009, Journal of Infectious Diseases.
[7] Thomas J. Sweet,et al. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. , 2005, Antiviral research.
[8] S. Hillier,et al. Why Nonoxynol-9 May Have Failed to Prevent Acquisition of Neisseria gonorrhoeae in Clinical Trials , 2005, Sexually transmitted diseases.
[9] Y. Seu,et al. Fungicidal Effect of Resveratrol on Human Infectious Fungi , 2005, Archives of pharmacal research.
[10] C. Elkins,et al. Haemophilus ducreyi Outer Membrane Determinants, Including DsrA, Define Two Clonal Populations , 2005, Infection and Immunity.
[11] W. Stamm,et al. In Vitro Microbicidal Activities of Cecropin Peptides D2A21 and D4E1 and Gel Formulations Containing 0.1 to 2% D2A21 against Chlamydia trachomatis , 2002, Antimicrobial Agents and Chemotherapy.
[12] P. Mayaud,et al. Interventions against sexually transmitted infections (STI) to prevent HIV infection. , 2001, British medical bulletin.
[13] J. Docherty,et al. Resveratrol selectively inhibits Neisseria gonorrhoeae and Neisseria meningitidis. , 2001, The Journal of antimicrobial chemotherapy.
[14] D. Taylor-Robinson,et al. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[15] A. Waterhouse,et al. Resveratrol: Isomeric Molar Absorptivities and Stability , 1996 .
[16] G. Schmid,et al. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States , 1992, Antimicrobial Agents and Chemotherapy.